In this Issue
One must consider a variety of issues, including patients’ adherence to prescribed therapy, the complexity of their dosing regimens, and the safety and efficacy of the drugs themselves.
By Gillian McDermott, Editor-in-Chief, featuring a sidebar interview with Wiley Chambers, MD
By Steven V. L. Brown, MD, FACS
Screening asymptomatic, high-risk patients for glaucoma.
By Ronald L. Fellman, MD
Approaches to traumatic iridodialysis and cyclodialysis.
By William Eric Sponsel, MB, ChB, MD
Methods for decreasing pigment particles in the anterior chamber in exfoliation syndrome and pigment dispersion syndrome.
By Wisam Shihadeh, MD, and Robert Ritch, MD
Glaucoma researchers from around the world presented hundreds of posters and papers at the annual meeting in Fort Lauderdale, Florida.
By Lisandro Sakata, MD, and Christopher A. Girkin, MD
Surgical considerations with and management of hypotony maculopathy.
By Jonathan G. Crowston, MD, PhD, and Robert N. Weinreb, MD, With Jeffrey M. Liebmann, MD
By Richard P. Wilson, MD
Differentiating between the various causes of blockage.